(Q28374326)

1

0 references

C Westling

2

0 references

G Giménez-Gallego

3

0 references

U Lindahl

4

0 references

M Salmivirta

Journal of Biological Chemistry

5

0 references

language of work or name

English

0 references

publication date

22 October 1999

0 references

published in

0 references

volume

274

0 references

issue

43

0 references

page(s)

30631-5

0 references

cites work

Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Basic FGF attenuates amyloid beta-peptide-induced oxidative stress, mitochondrial dysfunction, and impairment of Na+/K+-ATPase activity in hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

The binding of basic fibroblast growth factor to Alzheimer's neurofibrillary tangles and senile plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Regulated diversity of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Structure of heparan sulphate from human brain, with special regard to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Mode of interaction between platelet factor 4 and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

High-level synthesis in Escherichia coli of shortened and full-length human acidic fibroblast growth factor and purification in a form stable in aqueous solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Identification of oversulphated galactosaminoglycans in intestinal-mucosal mast cells of rats infected with the nematode worm Nippostrongylus brasiliensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Heparin structure and interactions with basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

A detergent-insoluble membrane compartment contains A beta in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Basic fibroblast growth factor-heparan sulphate complex in the human dialysis-related amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

A modified uronic acid carbazole reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631

Arrest of beta-amyloid fibril formation by a pentapeptide ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.43.30631